Adams Ted D, Arterburn David E, Nathan David M, Eckel Robert H
Intermountain LiVe Well Center, Intermountain Healthcare, and Division of Cardiovascular Genetics, University of Utah, Salt Lake City, UT
Group Health Research Institute, Seattle, WA.
Diabetes Care. 2016 Jun;39(6):912-23. doi: 10.2337/dc16-0157.
Understanding of the long-term clinical outcomes associated with bariatric surgery has recently been advanced. Research related to the sequelae of diabetes-in particular, long-term microvascular and macrovascular complications-in patients who undergo weight-loss surgery is imperative to this pursuit. While numerous randomized control trials have assessed glucose control with bariatric surgery compared with intensive medical therapy, bariatric surgery outcome data relating to microvascular and macrovascular complications have been limited to observational studies and nonrandomized clinical trials. As a result, whether bariatric surgery is associated with a long-term reduction in microvascular and macrovascular complications when compared with current intensive glycemic control therapy cannot be determined because the evidence is insufficient. However, the consistent salutary effects of bariatric surgery on diabetes remission and glycemic improvement support the opportunity (and need) to conduct high-quality studies of bariatric surgery versus intensive glucose control. This review provides relevant background information related to the treatment of diabetes, hyperglycemia, and long-term complications; reports clinical findings (to date) with bariatric surgery; and identifies ongoing research focusing on long-term vascular outcomes associated with bariatric surgery.
近年来,人们对减肥手术的长期临床结果有了更深入的了解。对于接受减肥手术的患者,研究糖尿病后遗症,特别是长期微血管和大血管并发症,对于这一研究至关重要。虽然许多随机对照试验评估了减肥手术与强化药物治疗相比对血糖的控制情况,但与微血管和大血管并发症相关的减肥手术结果数据仅限于观察性研究和非随机临床试验。因此,由于证据不足,无法确定与目前强化血糖控制治疗相比,减肥手术是否能长期减少微血管和大血管并发症。然而,减肥手术对糖尿病缓解和血糖改善的持续有益作用支持了开展减肥手术与强化血糖控制的高质量研究的机会(和必要性)。本综述提供了与糖尿病、高血糖和长期并发症治疗相关的背景信息;报告了减肥手术的临床研究结果(截至目前);并确定了正在进行的关于减肥手术相关长期血管结局的研究。